Chronologic age is the dominant risk factor for coronary artery disease but the features of aging promoting coronary artery disease are poorly understood. Advances in human genetics and population-based genetic profiling of blood cells have uncovered the surprising role of age-related subclinical leukemogenic mutations in blood cells, termed "clonal hematopoiesis of indeterminate potential," in coronary artery disease. Such mutations typically occur in DNMT3A, TET2, ASXL1, and JAK2. Murine and human studies prioritize the role of key inflammatory pathways linking clonal hematopoiesis with coronary artery disease. Increasingly larger, longitudinal, multiomics analyses are enabling further dissection into mechanistic insights. These observations expand the genetic architecture of coronary artery disease, now linking hallmark features of hematologic neoplasia with a much more common cardiovascular condition. Implications of these studies include the prospect of novel precision medicine paradigms for coronary artery disease.
CITATION STYLE
Natarajan, P. (2023, January 1). Genomic Aging, Clonal Hematopoiesis, and Cardiovascular Disease. Arteriosclerosis, Thrombosis, and Vascular Biology. Lippincott Williams and Wilkins. https://doi.org/10.1161/ATVBAHA.122.318181
Mendeley helps you to discover research relevant for your work.